HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #cemark--Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking.
Acadian Asset Management LLC boosted its stake in Hologic, Inc. (NASDAQ: HOLX) by 333.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
After a strong Q4 rebound, HOLX's Breast Health takes center stage in the company's upcoming private equity takeover.
Hologic posts solid Q4 gains with earnings and revenue beat, margin expansion, and a buyout deal by Blackstone and TPG.
Hologic (HOLX) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.01 per share a year ago.
Although the revenue and EPS for Hologic (HOLX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Str
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025.
Hologic (NASDAQ: HOLX - Get Free Report) is projected to release its Q4 2025 results after the market closes on Monday, November 3rd. Analysts expect Hologic to post earnings of $1.10 per share and re
Hologic's $18.3B buyout deal and Abbott's strong growth across key segments set up a close contest for MedTech investors.
We are investigating the fairness of the proposed sale of Hologic to Blackstone and TPG for $76.00 per share in cash and a CVR for up to $3.00 per share.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE